Auris Health, Inc. v. Noah Medical Corporation

District Court, N.D. California·Decided February 13, 2024·No. 3:22-cv-08073·Unknown

Opinion

AURIS HEALTH, INC., et al., Case No. 22-cv-08073-AMO (LJC)

Plaintiffs, ORDER GRANTING IN PART AND DENYING IN PART JOINT v. DISCOVERY LETTER BRIEF; GRANTING ADMINISTRATIVE NOAH MEDICAL CORPORATION, et al., MOTION TO CONSIDER WHETHER ANOTHER PARTY’S MATERIAL Defendants. SHOULD BE SEALED

Pending before the Court is the parties’ Joint Discovery Letter Brief. ECF No. 118. The parties primarily dispute how much of Defendant Noah Medical Corporation’s (Noah) proprietary source code Plaintiffs Auris Health, Inc. (Auris), Verb Surgical Inc. (Verb), and Cilag GmbH International (Cilag) (collectively, Plaintiffs) should be allowed to access and review during discovery. The Court held a hearing on February 2, 2024. ECF No. 123. Having carefully considered the parties’ arguments and relevant authority, and for the reasons stated below, the Court hereby GRANTS IN PART and DENIES IN PART the relief requested in the Joint Discovery Letter Brief.1 The Court assumes the parties’ familiarity with the underlying facts of this case. Request 1 In connection with the Joint Discovery Letter Brief, Plaintiffs filed an Administrative Motion to File Under Seal, seeking to maintain under seal portions of the Joint Discovery Letter Brief that referenced details about Plaintiffs’ trade secrets. ECF No. 119. The Court granted the motion on the record at the hearing on February 2, 2024, for good cause shown. ECF No. 123. Plaintiffs also filed an Administrative Motion to Consider Whether Another Party’s Material Should Be Sealed. ECF No. 120. Noah filed a statement in support of sealing as required by Civil Local Rule 79-5(f). ECF No. 122. The material in question referenced Noah’s commercially sensitive confidential information, specifically, source code parameters for a non-public instrument being for Production (RFP) No. 20, which was propounded by Plaintiffs, requests: “All software, firmware and tests written or modified by any Individual Defendant for Noah Medical.” ECF No. 118 at 2 (emphasis in original).2 Plaintiffs assert all of their source code-related trade secrets against Noah (id. at 2), but Diana Cardona Ujueta is the only individual Defendant accused of taking Plaintiffs’ source code. See ECF No. 36 (First Amended Complaint, or FAC) ¶¶ 113–19. Plaintiffs allege that Cardona Ujueta downloaded a large number of documents from her Auris- issued laptop, which included source code files, onto a personal external hard drive from April 2021 to when she left Auris in August 2021. Id. Cardona Ujueta joined Noah in September 2021 as an “R&I Senior Robotics and Controls Engineer.” Id. ¶ 121. There is forensic evidence indicating that she accessed some of these documents and files in September 2021. Id. ¶¶ 122–23. Noah does not dispute the fact that Cardona Ujueta took Plaintiffs’ documents, including source code files, with her after she left Auris. ECF No. 118 at 4. However, Noah points out that in a verified interrogatory response, Cardona Ujueta stated that she did not transfer Plaintiffs’ information to Noah. Id. And although Noah searched for these source code files in its systems and Cardona Ujueta’s Noah-issued laptop—using agreed- upon search terms negotiated by the parties—no responsive documents were found by Noah, and nothing was produced. Id. Noah claims that Cardona Ujueta is not a software engineer and did not write source code for Plaintiffs or for Noah. Id. at 4. Noah concedes, however, that one of her job responsibilities is to “test hardware using code written by others, to see if things are working correctly.” Id. Individual Defendant Mouslim Tatarkhanov was Noah’s Head of Research and Innovation Software. FAC ¶ 178. Tatarkhanov did write source code for Noah, specifically, code for motion control of prototype devices. ECF No. 118 at 3, 5. And Tatarkhanov also worked on software and firmware related to Auris’s products during his time with the company. FAC ¶ 175. But Plaintiffs do not assert any source-code related trade secrets against Tatarkhanov, which they claim is the result of Tatarkhanov reformatting his hard drives right before leaving Auris, meaning there is no forensic evidence that he took any source code files, as there is with Cardona Ujueta. ECF No. 118 at 3. Specifically, Plaintiffs allege that on February 22, 2021, the next business day after he resigned from Auris, Tatarkhanov downloaded over 60 Software Quality Management Documents from the Agile System, and three hours after this download completed, he erased the contents of one of his hard drives by reformatting that drive. FAC ¶ 176. On March 5, 2021, his last day at Auris, Tatarkhanov allegedly erased the contents of another Auris hard drive by reformatting the drive. Id. Plaintiffs claim that Tatarkhanov reformatted his hard drives without Auris’s permission, although Noah contends that he spoke to an IT employee before doing so, and that he “provided the names of employees who were aware of it or had reformatted their own laptops when leaving.” ECF No. 118 at 3, 5. At the hearing, Noah admitted that it does not know the name of the IT employee that Tatarkhanov spoke to, and that the employees referenced in the Joint Discovery Letter Brief were Tatarkhanov’s subordinates. Nevertheless, Tatarkhanov has told Plaintiffs that he only saved the files he downloaded to his Auris-issued laptop, not to an external device or account. Id. at 5. Like Cardona Ujueta, Tatarkhanov has served a verified discovery response stating that he did not transfer Plaintiffs’ information to Noah. Id. at 5. And as with Cardona Ujueta, Noah ran search terms in connection with Tatarkhanov—including terms with the file names of the 60 files Plaintiffs accuse Tatarkhanov of exfiltrating—and found no responsive documents to produce. Id. Apart from the particulars related to the parties’ present discovery dispute, the Court notes that there is a Stipulated Protective Order in this case. ECF No. 79. Section 7.3 of the Protective Order sets rules for the disclosure of Highly Confidential – Source Code information and items. Id. at 10–11. Rule 26(b)(1) of the Federal Rules of Civil Procedure allows parties to obtain “discovery regarding any nonprivileged matter that is relevant to any party’s claim or defense and proportional to the needs of the case, considering the importance of the issues at stake in the action, the amount in controversy, the parties’ relative access to relevant information, the parties’ expense of the proposed discovery outweighs its likely benefit.” The right to discovery, even plainly relevant discovery, is not limitless. Rule 26 allows the Court to deny discovery where: “(i) the discovery sought is unreasonably cumulative or duplicative, or can be obtained from some other source that is more convenient, less burdensome, or less expensive; (ii) the party seeking discovery has had ample opportunity to obtain the information by discovery in the action; or (iii) the proposed discovery is outside the scope permitted by Rule 26(b)(1).” Fed. R. Civ. P. 26(b)(2)(C). It is “[t]he [C]ourt’s responsibility, using all the information provided by the parties, [ ] to consider these and all the other factors in reaching a case-specific determination of the appropriate scope of discovery.” Fed. R. Civ. P. 26(b), Advisory Committee Notes (2015 Amendment). Plaintiffs want a forensic neutral firm to “identify source code files, firmware, and tests authored or modified by any Individual Defendant.” ECF No. 118 at 4. But in the Joint Discovery Letter Brief, Plaintiffs focus only on Defendants Cardona Ujueta and Tatarkhanov. Id. at 2–3. Noah believes Plaintiffs to be narrowing their source code request (id. at 4)

Free access — add to your briefcase to read the full text and ask questions with AI

Auris Health, Inc. v. Noah Medical Corporation, (N.D. Cal. 2024).

Auris Health, Inc. v. Noah Medical Corporation (Auris Health, Inc. v. Noah Medical Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.